Duplicate deal numbers have been identified for a limited number of generic OTC rates trades. Root cause has been identified and resolution is in progress. Affected deals will be assigned a new unique deal number and NASDAQ OMX will reach out bilaterally to all affected members within the next couple of days.
For further information please contact:
Jonas Buskas
jonas.buskas@nasdaqomx.com
+4684056620